NeuroPace Inc — Director's Dealing 2021

Oct 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21

Reporting Person: Ryan Renee (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-21	Stock Option (Right to Buy)	$17.00	A	21698	Acquired	2031-04-20	Common Stock (21698)	Direct

Footnotes

F1: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.